Codiak BioSciences Appoints EVP

Codiak BioSciences announced the appointment of Robert M. Brenner, M.D. as executive vice president and head of Research and Development. Dr. Brenner will serve on the executive leadership team and report to Codiak's president and chief executive officer, Douglas E. Williams, Ph.D.

"Dr. Brenner's experiences and accomplishments span the spectrum from research to commercial operations, in companies at a variety of stages of growth," said Dr. Williams. "He brings broad drug development skills in recombinant proteins, cell therapies and small molecules, which will help to grow the Codiak pipeline and platform while strengthening our foremost position in pioneering exosome therapeutics."